14 results
10-K
2021 FY
IOBT
IO Biotech Inc
31 Mar 22
Annual report
5:07pm
Gastrointestinal disorders
General disorders and administration site conditions
Hepatobiliary disorders
Infections and infestations
Injury, poisoning … of vision due to worsening known age-related macular degeneration
Traumatic eye injury
All patients exhibited peptide specific immune responses in T
10-Q
2021 Q3
IOBT
IO Biotech Inc
17 Dec 21
Quarterly report
4:55pm
and patients. There may also be increased risk of injury to patients if physicians attempt to use our products for these uses for which … of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. We could be held liable for any resulting damages
8-K
EX-10.1
uu4hs0llxsj5aq
6 Dec 21
Entry into a Material Definitive Agreement
9:00am
424B4
zvvck59cit
8 Nov 21
Prospectus supplement with pricing info
5:20pm
S-1/A
EX-10.12
0nmrtsxns
26 Oct 21
IPO registration (amended)
5:15pm
S-1
wtlcpvp 6ngy9nijvz
15 Oct 21
IPO registration
5:18pm
DRS/A
aqc90kg
6 Oct 21
Draft registration statement (amended)
12:00am
DRS/A
nibtu2
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
rnk56vs4ksf176yer1ww
3 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next